China Down Syndrome Market to 2032
Overview
The China Down Syndrome Market is expected to reach a 368.82 USD Million by 2032 and is projected to grow at a CAGR of 30.01% from 2025 to 2032.
Revenue, 2024 (USD Million)
94.72
Forecast, 2032 (USD Million)
368.82
CAGR, 2024 - 2032
30.01%
Report Coverage
China
China Down Syndrome Market 2018-2032 USD Million
China Down Syndrome Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 94.72 USD Million
- Projected Market Size (2032): 368.82 USD Million
- CAGR (2025-2032): 30.01%
Key Findings of China Down Syndrome Market
- The China Down Syndrome Market was valued at 94.72 USD Million in 2024.
- The China Down Syndrome Market is likely to grow at a CAGR of 30.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Trisomy 21 in Disease Type Segment accounted for the largest share of the market with a revenue of 88.00 USD Million
- The fastest growing segment Therapy Centers in End User Segment grew Fastest with a CAGR of 34.32% during the forecast period from 2024 to 2032.
China Down Syndrome Market Scope
China Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Distribution Channel
- Others
- Retail Sales
- Direct Tender
China Down Syndrome Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 94.72 USD Million |
| Market Value in 2032 | 368.82 USD Million |
| CAGR (2025-2032) | 30.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Treatment, Disease Type, End User, Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 94.72 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 94.72 USD Million in 2024.
Segments and Scope
-
China Down Syndrome Market to 2032, By Treatment
- Diagnosis is the largest segment in China Down Syndrome Market to 2032 with a revenue of 70.04 USD Million in the year 2024.
- Therapy is the Fastest growing segment in China Down Syndrome Market to 2032 with a Growth rate of 29.09 % in forecast period 2025-2032.
-
China Down Syndrome Market to 2032, By Disease Type
- Trisomy 21 is the largest segment in China Down Syndrome Market to 2032 with a revenue of 88.00 USD Million in the year 2024.
- Trisomy 21 is the Fastest growing segment in China Down Syndrome Market to 2032 with a Growth rate of 30.34 % in forecast period 2025-2032.
-
China Down Syndrome Market to 2032, By End User
- Hospital is the largest segment in China Down Syndrome Market to 2032 with a revenue of 57.09 USD Million in the year 2024.
- Therapy Centers is the Fastest growing segment in China Down Syndrome Market to 2032 with a Growth rate of 29.80 % in forecast period 2025-2032.
-
China Down Syndrome Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in China Down Syndrome Market to 2032 with a revenue of 68.64 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in China Down Syndrome Market to 2032 with a Growth rate of 31.79 % in forecast period 2025-2032.
China Down Syndrome Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| PerkinElmer Inc. | |||
| Illumina, Inc. | |||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
China Down Syndrome Market Geographical Sales Distribution, 2018-2032 USD Million
China Down Syndrome Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, End User, Distribution Channel.
China Down Syndrome Market was valued at USD 94.72(Revenue in USD Million) in 2020.
China Down Syndrome Market is projected to grow at a CAGR of 30.01% during the forecast period of 2024 to 2032.
The Trisomy 21 segment is expected to dominate the China Down Syndrome Market, holding a largest market share of 88.00 USD Million in 2024
China Down Syndrome Market Scope
China Down Syndrome Market Segmentation & Scope
Treatment
- Therapy
- Diagnosis
Disease Type
- Mosaic Down Syndrome
- Translocation Down Syndrome
- Trisomy 21
End User
- Others
- Therapy Centers
- Homecare Setting
- Clinics
- Hospital
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The China Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, End User, Distribution Channel.
China Down Syndrome Market was valued at USD 94.72(Revenue in USD Million) in 2020.
China Down Syndrome Market is projected to grow at a CAGR of 30.01% during the forecast period of 2024 to 2032.
The estimated market value of the China Down Syndrome Market for final year is USD 368.82 (USD Million).
China Down Syndrome Market Company Profiling
Frequently Asked Questions
The China Down Syndrome Market is segmented based on Segmentation Treatment, Disease Type, End User, Distribution Channel.
China Down Syndrome Market was valued at USD 94.72(Revenue in USD Million) in 2020.
China Down Syndrome Market is projected to grow at a CAGR of 30.01% during the forecast period of 2024 to 2032.
The estimated market value of the China Down Syndrome Market for final year is USD 368.82 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.